Salient Surgical Lands $17,900,000 Series F Financing

  • Feed Type
  • Date
  • Company Name
    Salient Surgical
  • Mailing Address
    One Washington Center Dover, NH 03820
  • Company Description
    TissueLink Medical provides devices that reduce surgical blood loss. Utilizing TissueLink’s saline-enhanced radio-frequency technology allows surgeons to control bleeding and improve patient outcomes.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series F
  • Proceeds Purposes
    Salient plans to use the net proceeds to fund programs aimed at continuing to expand its sales and marketing organization and accelerating development of new advanced energy products based on its proprietary Transcollation™ technology. Salient will also use a portion of the proceeds to fund working capital requirements and amortize term debt.
  • M&A Terms
  • Venture Investor
    Piper Jafray Ventures
  • Venture Investor
    Arnerich Messina & Associates, Inc.
  • Venture Investor
  • Venture Investor
    Rivervest Venture Partners

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

Comments are closed.